Qiagen GmbH QIAstat-Dx Respiratory SARS-CoV-2 Panel -US IVD qualitative test intended for recall — FDA Z-2245-2023
Identified a decreased performance reliability rate, Run abortions could cause delayed diagnosis since sample testing would have to be repeated